503B Compounding Pharmacy

In this clip, Patricia Kienle, BSPharm, MPA, FASHP, Director of Accreditation and Medication Safety at Cardinal Health Innovative Delivery Solutions, discusses key steps for performing an assessment of risk in compliance with USP 800.

At the American Pharmacy Purchasing Alliance’s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work.

Fred Massoomi, PharmD, FASHP, Senior Director at Visante, explains how USP 800 regulations will drive the use of closed system transfer devices in health care.

Fred Massoomi, PharmD, FASHP, senior director for Visante, discusses using closed system transfer devices.

In this clip, Fred Massoomi, PharmD, FASHP, Senior Director at Visante, offers advice on the best practices for USP 800 compliance, including gap analysis, individual monitoring, and education.

In this clip, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, compares the use of premixed with compound IV products for enhanced patient safety.

In this clip, Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, discusses the features and functionalities to consider when purchasing a new infusion pump.

Dennis Killian, PharmD, PhD, Director of Pharmacy at Peninsula Regional Medical Center, talks about the benefits of using ready-to-use, premixed IV products versus compound IV products.

Our team is on site in Denver all week covering from ASHP Summer 2018.

Designed with exclusive new features for bidirectional electronic medical records integration.

In response to the numerous concerns regarding antineoplastic drugs and other medications that may threaten the health of patients and health care workers, the National Institute for Occupational Safety and Health (NIOSH) developed a list, updated biennially, of hazardous drugs.

The pharmacist-in-charge was out of town, but an order came in for a compounded chemotherapy medication that was needed the same day, so he authorized a technician to prepare it with no pharmacist present to supervise.

Each year, more than 8 million U.S. health care personnel are potentially exposed to hazardous medications. Acute and chronic health effects have been reported, including headaches, ocular problems, rashes, hair loss, adverse reproductive health, and increased cancer risk.

Officials with the FDA have issued 2 final guidance documents to help implement the 2018 Compounding Policy Priorities Plan, which explain the agency’s policies on the “essentially a copy” provisions of sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Priority areas that pharmacists should focus on ahead of USP .

To prepare for USP Chapter , pharmacies must ensure that they are meeting the right compounding compliance standards.

Pharmacists should be aware of what components they need to address to comply in order to prep themselves for USP standards.

When approaching a plan for handling hazardous drugs, leaders of each organization need to be proactive in complying with USP regulations.

In this clip, Jennifer Bruckart, CPhT, Director of Operations and Compliance at WeCare Pharmacy, discusses how community pharmacists can prepare for the new USP 800 regulations.

In this clip, Jennifer Bruckart, CPhT, Director of Operations and Compliance at WeCare Pharmacy, explains some of the key regulations included in USP 800 and how the new guidelines will impact compounding pharmacies.

According to an "FDA in Brief" report, officials with the FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV).

The Drug Quality and Security Act (DQSA) provides a framework for working with outsourcing facilities to meet federal regulatory standards.

The chapter, effective July 1, 2018, includes the entire drug handling process, from receipt to the proper disposal of both sterile and nonsterile products:

In this video from PainWeek 2017, Hal Blatman, MD, medical director of Blatman Health and Wellness Center, discusses how compounding pharmacists can help patients with chronic pain.

In the evolving world of pharmacy practice, many are asking what is included in the key provisions of the United States Pharmacopeial Convention (USP) 800 when it comes to transport, storage, preparation, and compounding.

Top news of the day from across the health care landscape.

Clean rooms at the right conditions are necessary to ensure the quality and safety of the drug. Ned Milenkovich discusses how standards within the USP800 helps do this.